LFVN

Lifevantage Corporation Common Stock (Delaware)

5.29

USD

+0.07

+1.34%

Nov 09, 15:59 UTC -5

Closed

Pre-Market

5.04

-0.25

-4.73%

Lifevantage Corporation Common Stock (Delaware) (LFVN) Earnings

LFVN Earnings Reports

Positive Surprise Ratio

LFVN beat 13 of 25 last estimates.

52%

Next Report

Date of Next Report

Feb 02, 2027

Estimate for Q2 27 (Revenue/ EPS)

$42.49M

$0.08

Implied change from Q1 27 (Revenue/ EPS)

+14.46%

+60.00%

Implied change from Q2 26 (Revenue/ EPS)

-13.17%

-46.67%

Lifevantage Corporation Common Stock (Delaware) earnings per share and revenue

On Nov 09, 2026, LFVN reported earnings of 0.05 USD per share (EPS) for Q1 27, missing the estimate of 0.06 USD, resulting in a -22.60% surprise. Revenue reached 37.12 million, compared to an expected 41.30 million, with a -10.12% difference.

Looking ahead to Q2 27, -- analysts forecast an EPS of 0.08 USD, with revenue projected to reach 42.49 million USD, implying an increase of 60.00% EPS, and increase of 14.46% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

DENTSPLY SIRONA Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.31

Actual

$0.28

Surprise

-8.11%

Staar Surgical Co

Report Date

Nov 04, 2026 For Q3 26

Estimate

$0.05

Actual

$0.11

Surprise

+94.00%

Pro-Dex Inc New

Report Date

Oct 29, 2026 For Q1 27

Estimate

$0.68

Actual

$0.92

Surprise

+34.62%

McKesson Corporation

Report Date

Nov 04, 2026 For Q2 27

Estimate

$10.81

Actual

$11.68

Surprise

+8.04%

Cardinal Health, Inc.

Report Date

Nov 05, 2026 For Q1 27

Estimate

$2.96

Actual

$3.26

Surprise

+9.81%

Becton, Dickinson and Co.

Report Date

Nov 05, 2026 For Q4 26

Estimate

$4.10

Actual

$4.15

Surprise

+1.00%

West Pharmaceutical Services, Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$2.21

Actual

$2.66

Surprise

+20.21%

Align Technology Inc

Report Date

Oct 28, 2026 For Q3 26

Estimate

$2.83

Actual

$2.80

Surprise

-1.11%

Henry Schein Inc

Report Date

Nov 03, 2026 For Q3 26

Estimate

$1.38

Actual

$1.56

Surprise

+12.64%

Merit Medical Systems Inc

Report Date

Oct 29, 2026 For Q3 26

Estimate

$1.05

Actual

$1.12

Surprise

+5.67%

FAQ

What were Lifevantage Corporation Common Stock (Delaware)'s earnings and revenue for the latest quarter Q1 2027?

For Q1 2027, Lifevantage Corporation Common Stock (Delaware) reported EPS of $0.05, missing estimates by -22.6%, and revenue of $37.12M, -10.12% below expectations.

How did the market react to Lifevantage Corporation Common Stock (Delaware)'s Q1 2027 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Lifevantage Corporation Common Stock (Delaware) expected to report next?

The next earning report is scheduled for Feb 02, 2027.

What are the forecasts for Lifevantage Corporation Common Stock (Delaware)'s next earnings report?

Based on -- analysts, Lifevantage Corporation Common Stock (Delaware) is expected to report EPS of $0.08 and revenue of $42.49M for Q2 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.